Prologue Research International

Columbus, United States Founded: 1998 • Age: 28 yrs Acquired By Novella Clinical
Oncology focussed CRO, acquired by Novella Clinical in 2010

About Prologue Research International

Prologue Research International is a company based in Columbus (United States) founded in 1998 was acquired by Novella Clinical in June 2010.. Prologue Research International operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Oncotherapeutics and Abogen Biosciences, among others.

  • Headquarter Columbus, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Novella Clinical

    (Jun 02, 2010)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Prologue Research International

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Prologue Research International

Prologue Research International has secured backing from 1 investor. Prominent investors backing the company include Novella Clinical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Specialty CRO focussed exclusively solely on the needs of small to mid-sized oncology companies and medical device and diagnostics companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Prologue Research International

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Prologue Research International

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Prologue Research International Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Prologue Research International

Prologue Research International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Oncotherapeutics and Abogen Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
domain founded_year HQ Location
Contract-based oncology clinical trial services are provided by Aster Insights.
domain founded_year HQ Location
Cancer vaccine research and development is conducted by CancerVax.
domain founded_year HQ Location
Preclinical and clinical oncology drug development services are provided.
domain founded_year HQ Location
mRNA-based therapeutics are developed for cancer and infectious diseases.
domain founded_year HQ Location
CRO offering clinical development services for oncology drugs
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Prologue Research International

Frequently Asked Questions about Prologue Research International

When was Prologue Research International founded?

Prologue Research International was founded in 1998.

Where is Prologue Research International located?

Prologue Research International is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.

What does Prologue Research International do?

Prologue Research International was founded in 1998 in Columbus, United States, operating as an oncology-focused contract research organization. Phase I through IV clinical development services were delivered to oncology drug developers, covering protocol design, site initiation and management, project oversight, monitoring, pharmacovigilance, data handling, biostatistics, regulatory support, and quality auditing. Additional operations were based in Russia and the UK. Acquisition by Novella Clinical occurred in 2010.

Who are the top competitors of Prologue Research International?

Prologue Research International's top competitors include Helsinn, CancerVax and OnCusp.

Who are Prologue Research International's investors?

Prologue Research International has 1 investor. Key investors include Novella Clinical.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available